Close

Form 8-K VASCULAR SOLUTIONS INC For: May 01

May 4, 2015 4:48 PM EDT

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
Date of Report: May 1, 2015

(date of earliest event reported)

 VASCULAR SOLUTIONS, INC.

(Exact name of registrant as specified in its charter)

Commission File Number: 0-27605
 

 
Minnesota
 
41-1859679
(State or other jurisdiction of incorporation)
 
(IRS Employer Identification No.)
 
6464 Sycamore Court North
Minneapolis, Minnesota 55369
(Address of principal executive offices)

 (763) 656-4300
(Registrant’s telephone number, including are code)

 Not Applicable
(Former name or former address, if changed since last report)
 


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act ( 17 CFR 240.13e-4(c))

 

Item 5.07.   Submission of Matters to a Vote of Security Holders.

At the Annual Meeting of Shareholders of Vascular Solutions, Inc. (the “Company”) held on May 1, 2015, the Company’s shareholders approved each of the following proposals, which were set forth in the Proxy Statement for the 2015 Annual Meeting of Shareholders:

Proposal 1

 The Company’s shareholders elected each of the seven director nominees to a one-year term and until the director’s successor is elected and qualified (except in the case of earlier death, resignation or removal) as follows:
 
 
FOR
WITHHOLD
BROKER NON-VOTE
Martin Emerson
12,751,215
245,977
3,209,432
John Erb
12,561,163
436,029
3,209,432
Richard Kramp
12,923,089
74,103
3,209,432
Richard Nigon
11,353,129
1,644,063
3,209,432
Paul O’Connell
12,610,476
386,716
3,209,432
Howard Root
12,613,315
383,877
3,209,432
Jorge Saucedo
12,752,032
245,160
3,209,432
 
Proposal 2

The Company’s shareholders approved an amendment to the Vascular Solutions, Inc. Stock Option and Stock Award Plan:
 
FOR
AGAINST
ABSTAIN
BROKER NON-VOTE
11,309,532
1,558,492
129,168
3,209,432
 
Proposal 3

The Company’s shareholders ratified the appointment of Baker Tilly Virchow Krause, LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2015:
 
FOR
AGAINST
ABSTAIN
BROKER NON-VOTE
16,111,777
91,563
3,284
0


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 
VASCULAR SOLUTIONS, INC.
       
Date: May 4, 2015
By:
/s/ Gordon Weber
 
   
Gordon Weber
   
Its: Secretary




Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings